Next Article in Journal
Risk Groups and Psychosocial Factors for the Pandemic (COVID-19)
Previous Article in Journal
Evaluating Sexual Health in Women with Multiple Sclerosis: A Study on the Interplay of Disability and Quality of Life
Previous Article in Special Issue
Low-Volume Squat Jump Training Improves Functional Performance Independent of Myofibre Changes in Inactive Young Male Individuals
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Healthcare
Volume 12
Issue 13
10.3390/healthcare12131240
healthcare-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Effects of Acute Beetroot Juice Supplementation and Exercise on Cardiovascular Function in Healthy Men in Preliminary Study: A Randomized, Double-Blinded, Placebo-Controlled, and Crossover Trial

by
**e Yuschen
1,†,
Jae-Ho Choi
1,†,
Jisoo Seo
1,
Yerin Sun
1,
Eunjoo Lee
1,
Sung-Woo Kim
1,2 and
Hun-Young Park
1,2,*
1
Department of Sports Medicine and Science, Graduate School, Konkuk University, 120 Neungdong-ro, Gwang**-gu, Seoul 05029, Republic of Korea
2
Physical Activity and Performance Institute, Konkuk University, 120 Neungdong-ro, Gwang**-gu, Seoul 05029, Republic of Korea
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work and share the first authorship.
Healthcare 2024, 12(13), 1240; https://doi.org/10.3390/healthcare12131240
Submission received: 23 May 2024 / Revised: 19 June 2024 / Accepted: 20 June 2024 / Published: 21 June 2024
(This article belongs to the Special Issue Acute and Chronic Adaptations to Exercise and Complementary Interventions)
Browse Figures
Versions Notes

Abstract

:
Nitrate-rich beetroot juice (NRBRJ) can potentially enhance exercise performance and improve cardiovascular function, leading to an increased use of NRBRJ over the years. However, the combined effects of NRBRJ supplementation and exercise on cardiovascular function remain unclear. Therefore, this study compared cardiovascular function responses to submaximal exercise with either placebo (PLA) or NRBRJ supplementation in healthy men. Twelve healthy men (aged 25.2 ± 2.3 years) completed the 30-min submaximal cycle ergometer exercise trials corresponding to 70% maximal heart rate (HRmax) with either PLA or NRBRJ supplementation in a random order. The mean exercise load, heart rate (HR), stroke volume (SV), cardiac output (CO), systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), and total peripheral resistance (TPR) were measured during exercise. The brachial–ankle pulse wave velocity (baPWV) and flow-mediated dilation (FMD) were measured before and after exercise. NRBRJ supplementation was more effective than PLA in increasing the mean exercise load and decreasing DBP and MAP during submaximal exercise. Furthermore, baPWV decreased in the NRBRJ trial and was considerably lower after exercise in the NRBRJ-supplemented group than in the PLA-supplemented group. FMD significantly increased in the PLA and NRBRJ trials; however, NRBRJ supplementation demonstrated a significantly higher FMD before and after exercise than PLA supplementation. In conclusion, acute NRBRJ supplementation and exercise were more effective than PLA supplementation and exercise in improving aerobic exercise capacity and cardiovascular function in healthy men.

1. Introduction

Beetroot contains a higher amount of nitrate ( N O 3 − ) than other vegetables such as lettuce, spinach, endive, and turnip [1,2,3]. N O 3 − intake can improve athletic performance, and over the years, the use of nitrate-rich beetroot juice (NRBRJ) from Beta vulgris by athletes in endurance training has increased [4]. After NRBRJ intake, N O 3 − in the body circulates in the plasma, is concentrated by approximately 25% in the salivary glands, and is secreted into the mouth, of which 20% is converted from N O 3 − to nitrite by symbiotic bacteria on the tongue and swallowed [5]. The converted nitrite is directly absorbed from the stomach or is partially reduced to nitric oxide (NO) by stomach acid [5]. The NO and nitrite produced are absorbed into the blood vessels through systemic circulation, dilating blood vessels and improving cardiovascular functions such as reducing blood pressure (BP) [6]. Additionally, it was found to destroy reactive nitrogen (RNS) and oxygen (ROS) species, suggesting that absorbed N O 3 − from NRBRJ consumption also provides an antioxidant effect [7,8,9].
NO can activate cardiomyocytes (e.g., decreased oxygen consumption and decreased apoptosis), coronary circulation (e.g., vasodilatation, increase in coronary blood flow, antithrombotic and anti-inflammatory action, and endothelial dysfunction improvement), myocardium, and the conductive system (e.g., negative inotropic and chronotropic effects) within the human body [10]. These effects are mediated through the NO/cGMP pathway, local mitochondrial metabolism regulation, calcium ion regulation in myocardial cells, and autonomic nervous system control [10].
Previous studies have demonstrated that NRBRJ supplementation enhances vascular function through various mechanisms (inhibit platelet aggregation, promotion of vasodilation, inhibition of vasoconstriction, and production of free radicals) [11,12,13]. In some studies, the largest BP reduction occurred 2–3 h after NRBRJ ingestion, equivalent to the peak plasma nitrite ( N O 2 − ) concentration observed [14,15,16]. As such, N O 2 − may provide vasculoprotective effects when classical NO synthesis is impaired [14]. This acutely lowers arterial BP, supplements endothelial function (measured using flow-mediated dilation, FMD) during ischemia, and inhibits platelet aggregation due to NO bioconversion [14].
Regular exercise is known to reduce the risk of cardiovascular disease by improving vascular function by regulating oxidative stress (OS) and endothelial function [17,18]. One of the mechanisms by which exercise improves vascular endothelial function is an increase in blood flow and shear stress, which may improve vascular homeostasis through the increase in NO bioavailability in the endothelium [19,20]. Furthermore, there is an improvement in the ability to produce vasodilators such as NO and prostacyclin, which may influence endothelial function [21]. Previous studies conducted through this mechanism reported that regular exercise decreased total peripheral resistance (TPR), heart rate (HR), and BP and increased arterial baroreflex sensitivity and cardiovascular variability [12].
Several studies have been conducted on the effects of NRBRJ supplementation and exercise on athletic performance, and the rationale is based on several factors. First, after NRBRJ supplementation, NO and N O 2 − increase blood flow [22,23,24], which can increase oxygenation to the muscles, thereby improving exercise capacity [25,26]. Second, the plasma N O 2 − bioavailability is increased, which acts as a regulator of hypoxic signaling for NO-induced vasodilatory capacity [7,24,27]. Third, the hypoxic and acidic conditions noted during exercise promote N O 2 − -to-NO reduction and enhance the physiological effects of exogenously ingested NRBRJ [23]. These effects can improve exercise capacity by altering the metabolic and hemodynamic responses of muscles to exercise [28,29]. Previous studies have comprehensively validated the effects of NRBRJ supplementation and exercise on exercise capacity. however, there is a paucity of relevant studies on changes in cardiovascular function before, during, and after exercise [30]. In particular, while there are many studies related to blood pressure, there is a lack of research on changes in arterial stiffness and endothelial function before and after exercise following NRBRJ supplementation [31]. This study aims to fill this research gap and investigate the additional effects of NRBRJ supplementation and exercise on cardiovascular function in healthy men.
Therefore, this study aimed to examine the additive effects of NRBRJ supplementation and exercise on cardiovascular function in healthy men compared to effects from placebo (PLA) supplementation and exercise. The hypothesis of the present study was that NRBRJ supplementation and exercise may enhance cardiovascular function in healthy men compared with PLA supplementation and exercise.

2. Materials and Methods

2.1. Participants

The participants included twelve healthy men who were nonsmokers and non-obese; had no history of musculoskeletal, cardiovascular, or pulmonary diseases; did not participate in any planned exercise program; and had not consumed any dietary supplements 6 months prior. All healthy men were identified as healthy via the Physical Activity Readiness Questionnaire for Everyone and were restricted from intake of cabbages (i.e., broccoli, cauliflower, red cabbage, etc.) for 2 weeks before study participation [16]. However, the physical activity and dietary intake of all participants were not investigated during the study period. The participants were briefed on the purpose and process of the study, and informed consent was obtained before initiation of the study.
In this study, the sample size was determined with the goal of achieving a test power exceeding 80%. A previous study involving healthy adults reported a mean change in blood pressure between the N O 3 − group and the PLA group as 10 mmHg, with a standard deviation (SD) of 9 mmHg [32]. Based on these findings, a G-power test was conducted with a significance level (α) of 0.05, a power level (1 − β) set to 0.8, and an effect size (dz) set to 1.11. The calculated sample size required to meet these criteria was determined to be a total of 10 participants. However, we considered dropouts and selected 12 research participants. The expected test power at this sample size exceeds 80%, and the normality test further supports the reasonableness of the selected sample size.
The physical characteristics of the participants are illustrated in Table 1. The trial was registered and disclosed to the Institutional Review Board of Konkuk University (7001355-202301-E-616) in Korea and was conducted according to the Declaration of Helsinki guidelines.

2.2. Study Design

The study design is shown in Figure 1. During the experimental period, all participants visited the laboratory thrice.
During the first visit, the participants fasted for >4 h, and their height and body composition were measured the morning after stabilization. Subsequently, all of the participants underwent a familiarization trial under non-intake conditions using the exercise protocol before the main trial for exercise program adaptation. The exercise protocol consisted of 30 min of endurance exercise on a cycle ergometer (Aero bike 75XLII; Konami Corporation, Tokyo, Japan) at the same HR level equivalent to 70% maximal HR (70% HRmax), calculated using the Miyashita formula (male = 209 − 0.69 × age) [33]. The target HR of the participants, 70% HRmax, was 136.5 ± 1.5 bpm.
In the study, we searched several studies for study design and found that exercising on a treadmill has limitations in measuring blood pressure. Therefore, a cycle ergometer was selected to obtain accurate data for measuring both blood pressure and cardiac function. The chosen exercise type and duration (30 min) were similar, and 70% of HRmax was used, referring to previous studies that evaluated cardiac function during exercise [33]. In addition, according to the American College of Sports Medicine (ACSM) guidelines, 70% of HRmax is considered a reasonable exercise intensity as it essentially corresponds to the medium-intensity level recommended for improving health [34].
On the second and third visits, all participants were instructed to fast and prohibit mouthwashing (gargle) and brushing for 12 h prior to testing in the laboratory [16]. Moreover, they were instructed to refrain from physical activity for 24 h prior to the test. All participants were asked to consume PLA and/or NRBRJ 2.5 h before exercise. Figure 2 illustrates the details of the PLA and NRBRJ supplements [35]. The NRBRJ supplement was 70 mL of Beet-It Sport Shot 400 (James White Ltd., Ashbocking, UK), which contains 400 mg of N O 3 − [35]. Prune juice (Sunsweet Growers Inc., Kingston upon Hull, UK) was selected as a PLA supplement because of its negligible N O 3 − levels (<0.01 mM) and similar consistency and color to those of NRBRJ supplementation [36]. Additionally, prior research has indicated that the carbohydrate and fiber content of the two supplements does not significantly affect the experiment [36]. Due to the red color of beetroot, side effects of NCBRJ consumption include red urine and red stool [35]. After 2.5 h of PLA and/or NRBRJ supplementation, all participants were evaluated for brachial–ankle pulse wave velocity (baPWV) and FMD before and after 30 min of endurance exercise. Moreover, the participants performed endurance exercises in a crossover randomized order with PLA and/or NRBRJ supplementation. A 7-day washout period was implemented between the second and third visits to ensure that the effects of the ingested substances did not carry over [15]. During 30 min of the endurance exercise session, the following parameters were measured: mean exercise load, TPR, cardiac output (CO), stroke volume (SV), HR, systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial pressure (MAP). All exercise parameters were measured at rest and at 5, 10, 20, and 30 min during the endurance exercise.
In all trials, the endurance exercise was conducted at the same temperature and humidity (23 ± 1 °C, 50% ± 5%) (environmental control chamber; NCTC-1, Nara Control, Seoul, Republic of Korea).

2.3. Outcome Measurements

2.3.1. Height and Body Composition

Height and body composition were measured using the Inbody 770 (Inbody, Seoul, Republic of Korea) in a light top and bottom. After fasting for at least 4 h before the test, the participants visited the laboratory. Each participant removed any metallic material adhering to their body, stood on the measuring device, and stepped on the electrode with bare feet. Height was obtained with the participants holding the handle of the measuring device with both hands and in an upright position with arms and legs slightly apart. Height (cm), body weight (kg), body mass index (kg/m2), fat-free mass(kg), body fat mass (kg), and body fat percentage (%) were measured.

2.3.2. Mean Exercise Load during Exercise

The mean exercise load corresponding to 70% HRmax during 30 min of endurance exercise on a cycle ergometer was automatically calculated using the instrument.

2.3.3. Cardiovascular Function during Exercise

A thoracic bioelectrical impedance device (PhysioFlow PF-05, Paris, France) was used to noninvasively measure HR and SV, which are cardiovascular function parameters. The bioimpedance device consisted of two impedance cardiography electrodes placed above the supraclavicular fossa at the base of the left side of the neck, two electrocardiography electrodes used to record an electrocardiogram (ECG), and two electrodes placed at the xiphoid process. Impedance cardiography measures changes in thoracic impedance during the cardiac cycle to calculate SV [37]. PhysioFlow is an impedance technique that emits high-frequency (75 kHz) and low-magnitude (1.8 mA) alternating electrical currents via skin electrodes during the cardiac cycle. This resulted in a waveform from which SV was calculated [38]. The HR is obtained from the R-R interval determined from the first derivative of the ECG and CO as calculated according to the following formula: CO = HR × SV. At rest and during exercise, PhysioFlow PF-05 was validated against the direct Fick method [38]. The brachial artery BP was measured via a manual sphygmomanometer UM-102 (Boryung A&D Systems, Seoul, Republic of Korea). The BP of each participant was measured by the same investigator throughout the experiment. MAP and TPR were calculated using the formula MAP = [(SBP − DBP) × 1/3]/DBP, TPR = MAP/CO. HR, SV, CO, SBP, DBP, MAP, and TPR were analyzed at rest and at 5, 10, 20, and 30 min during endurance exercise on a cycle ergometer.
The PWV is the best parameter for evaluating arterial stiffness. Therefore, the baPWV was measured using an automatic Oscillo metric device (VP-1000plus, Omron, Osaka, Japan) before and after exercise. Before measurement, participants wore sensor cuffs on both the upper arms and ankles. For HR monitoring, phonocardiogram electrodes were worn on the left edge of the sternum and ECG electrodes on both wrists. Resting baPWV was measured after resting for at least 30 min, and after-exercise baPWV was measured within 10 min of the completion of exercise for each trial [39].
FMD refers to the dilation (widening) of an artery when the blood flow increases in that artery. The release of NO by endothelial cells is the primary cause of FMD. Therefore, FMD of the brachial artery was measured to evaluate vascular endothelial function using noninvasive Doppler ultrasound (UNEX-EF, Tokyo, Japan) before and after exercise. After the measurement, blood was removed for 5 min by increasing the blood pressure by 50 mmHg based on resting BP. After 5 min, deflation was automatically recorded for the next 2 min to evaluate the diameter and blood flow rate, and the calculated FMD (FMD = [reactive hyperemia diameter − baseline diameter] × 100%) was used. Resting FMD was measured after resting for at least 30 min, and after-exercise FMD was measured within 10 min of the completion of exercise for each trial. The formula used was %FMD = (Maximal diameter [mm] − Resting diameter [mm]/Resting diameter [mm]) × 100 [40].

2.4. Statistical Analysis

All statistical analyses were conducted using SPSS version 28.0 (IBM Corp., Armonk, NY, USA). Data are presented as mean ± standard deviation. The normality of the distribution of all outcome variables was verified using the Shapiro–Wilk W-test before the parametric tests. First, a paired t-test was used to compare the mean exercise load during the PLA trial with that of the NRBRJ trial. Second, a two-way analysis (supplement × time) of variance (ANOVA) with repeated measures was used to assess the presence of interactions (supplement × time) and main effects (supplement or time). When the ANOVA revealed a significant interaction or main effect within the supplement, a Bonferroni post hoc test and paired t-test were used to identify within-supplement differences at each time point. The effect size in ANOVA can be represented as partial eta-squared values, and the effect size was computed as partial eta-squared values (ηp2; small: ≥ 0.01, medium: ≥0.06, large: ≥0.14). Partial eta-squared is a measure of the proportion of the total variance in a dependent variable that is associated with the effect of an independent variable after accounting for other variables [41]. The level of significance was set a priori at p < 0.05.

3. Results

3.1. Mean Exercise Load during Submaximal Exercise

A significant difference was observed in the mean exercise load at 70% HRmax during the 30 min exercise between the two trials (Figure 3). The NRBRJ supplement demonstrated a greater increase in exercise load (mean change, 8.58 watts; 95% confidence interval, 0.77, 16.4; p < 0.05) than the PLA supplement.

3.2. Cardiovascular Function before, during, and after Submaximal Exercise

3.2.1. Cardiovascular Function during Exercise

Figure 4 shows a significant interaction in DBP (p = 0.03, ηp2 = 0.319) and a significant main effect within each supplement in DBP (p = 0.001, ηp2 = 0.699) and MAP (p = 0.007, ηp2 = 0.574). In the post hoc analysis, the NRBRJ supplement significantly decreased DBP (p < 0.05) at rest and at 5, 20, and 30 min of exercise compared with the PLA supplement. Additionally, the nitrate supplement showed a significantly lower MAP (p < 0.05) than the PLA supplement at rest and after 20 and 30 min of exercise. However, no significant difference was found in HR, SV, CO, SBP, or TPR during the 30 min exercise at 70% HRmax between the PLA- and NRBRJ-supplemented groups.

3.2.2. Pulse Wave Velocity and Flow-Mediated Dilation before and after Exercise

No significant interaction was noted between supplementation and exercise in terms of baPWV or FMD (Figure 5). However, a significant main effect within each supplement was found in baPWV (p = 0.049, ηp2 = 0.365) and FMD (p = 0.001, ηp2 = 0.723). Post hoc analyses showed that baPWV significantly decreased in the NRBRJ trial (p < 0.05) and that baPWV showed a significantly lower value after exercise in the NRBRJ supplementation than in the PLA supplementation (p < 0.05). FMD significantly increased via the PLA (p < 0.05) and NRBRJ trials (p < 0.05); however, NRBRJ supplementation demonstrated a significantly higher FMD value before (p < 0.05) and after exercise (p < 0.05) than PLA supplementation.

4. Discussion

According to our study hypothesis, NRBRJ supplementation and exercise may induce additive improvements in cardiovascular function parameters in healthy men compared to PLA supplementation and exercise. Consistent with this hypothesis, the findings of this study revealed that acute dietary N O 3 − supplementation and exercise increased the mean exercise load and decreased DBP and MAP during 30 min of submaximal endurance exercise at 70% HRmax compared with PLA supplementation. Additionally, the NRBRJ supplementation demonstrated greater improvements in baPWV and FMD than the PLA supplementation.
Compared to the PLA supplementation, the N O 3 − supplementation achieved a higher mean exercise load during submaximal endurance exercise with 70% HRmax, which aligns with previous findings [42]. In the preceding study, the NRBRJ supplement group conducted a 30 min cycling session at Wmax 45% and Wmax 65%, followed by a 10 km time trial (TT). The results showed that the NRBRJ supplementation group improved power output and TT performance while decreasing VO2 during submaximal exercise [42]. In another study, NRBRJ supplements improved the performance in a 50-mile cycling time trial, achieving a higher average exercise load during submaximal endurance exercise [43]. In this study, VO2 was not measured; hence, confirming whether there was a decrease in VO2 was not possible. However, the fact that the NRBRJ supplementation group attained a higher average exercise load during submaximal endurance exercise aligns with previous research.
NRBRJ supplementation is believed to enhance higher exercise economy, resulting in a greater power output at the same oxygen consumption or HR levels. This is considered a crucial factor influencing cardiovascular endurance [44]. Moreover, NRBRJ supplementation can potentially convert into a potent vasodilator [45], NO, increasing blood flow to muscle tissues. This aspect allows for a more efficient removal of waste products from muscles through enhanced blood circulation, delaying the onset of fatigue [29]. Cermak et al. [42] suggested that NO can reduce the “slippage” of mitochondrial proton pumps or weaken the expression of uncoupling proteins, thereby lowering the total ATP cost of muscle-force production and improving the efficiency of oxidative phosphorylation. Another study reported that it can improve exercise performance by improving skeletal muscle mitochondrial efficiency [42,46,47]. Considering these factors, in this study, it can elucidate the observed higher power output during cycling in the NRBRJ supplementation group.
Previous studies on the effects of NRBRJ supplementation on cardiovascular parameters have yielded interesting results. In this study, NRBRJ supplementation considerably lowered DBP at rest and during various exercise intervals, which is consistent with previous findings [36,48]. The N O 3 − consumed through NRBRJ supplementation can generate exogenous NO via the N O 3 − – N O 2 − –NO pathway. The produced NO has the potential to enhance endothelial cell function, reducing peripheral resistance, which is a crucial factor in regulating DBP [49]. Furthermore, after being absorbed into the bloodstream, it can be taken up by vascular smooth muscle cells, activating the NO-cGMP-protein kinase G signaling pathway. This activation can induce vasodilation, potentially influencing blood pressure [50].
In this study, a decrease in SBP was not observed; however, the effects of a reduction in both SBP and DBP after NRBRJ consumption have been well established through numerous studies [11,51]. Most studies involved measuring blood pressure after consuming NRBRJ at rest, and, in a previous study that measured blood pressure during exercise, no changes were noted in either SBP or DBP [52]. These results were similar to a previous study that investigated blood pressure responses to HR during exercise in a population with normal blood pressure (men: 1033 participants) [52,53]. Moreover, the N O 3 − quantity contained in NRBRJ may also be associated with the observed effects. However, in this study, the rationale for the lack of decrease in SBP remains limited. Additionally, this study found that NRBRJ supplementation did not increase CO, which is contrary to the previous study by Zamani et al. [54] that reported N O 3 −   supplementation increased CO. This discrepancy in results may be due to the differences in exercise intensity. In the moderate-intensity exercise (70% HRmax) used in this study, Type Ⅰ muscle fibers, which use oxygen efficiently, are primarily activated, potentially limiting the additional effects of N O 3 − supplementation [55]. In contrast, high-intensity exercise activates Type Ⅱ muscle fibers, which have high oxygen and energy demands, allowing nitrate supplementation to significantly enhance performance [56]. Furthermore, the results of this study showed improvements in FMD following NRBRJ supplementation and exercise. Improvements in FMD suggest an increase in blood flow from arterioles to capillaries and from capillaries to muscle fibers [57,58].
Regarding vascular function and compliance, NRBRJ supplementation resulted in a decrease in baPWV after exercise compared to PLA supplementation. Limited research has been conducted on the effects of N O 3 − supplementation on PWV before and after exercise. A decrease in PWV implies enhanced vascular compliance, which is influenced by various factors. Some studies have indicated that PWV reduction may be due to changes in the aortic distending pressure [59]. The consumed N O 3 − may also reduce PWV by regulating sympathetic nervous system tension [60]. Furthermore, an increase in FMD, an indicator of endothelial function, was observed in this study during both rest and after-exercise periods with NRBRJ supplementation. The NO generated after N O 3 − intake can regulate the expression of vascular endothelial growth factor (VEGF) and inhibit ROS production [61,62]. Elevated ROS levels impair endothelial function, whereas NO can activate antioxidant defense systems, thereby reducing the ROS production rate and promoting an increase in FMD [63,64].
In this study, we explored the effects of NRBRJ supplementation on cardiovascular function before, after, and during exercise. The research findings showed that NRBRJ supplementation, compared to PLA supplementation, led to a greater power output during exercise. Additionally, it significantly reduced DBP during both rest and exercise and was found to decrease baPWV velocity through enhanced vascular compliance. These results indicate that NRBRJ supplementation may enhance beneficial effects on cardiovascular function, thereby increasing aerobic capacity during exercise. The results of this study can provide useful reference material for the general public and athletes when selecting sports supplements.

5. Limitations

The present study has several limitations. (1) In this study, we asked participants to limit their intake of products such as broccoli and cauliflower that interfere with the reduction in N O 3 − - N O 2 − -NO. Additionally, the use of mouthwash was restricted during study participation [16]. However, we did not equally restrict the diet of the participants over the procedure of the study. (2) Since plasma and urine measurements were not conducted in this study, we were unable to determine the changes in N O 3 − - and N O 2 − concentrations in plasma and urine following NRBRJ supplementation. (3) The normality of the distribution of all outcome parameters was verified using the Shapiro–Wilk W-test prior to the parametric tests; however, the small sample size may limit the interpretation of the results of this study.

6. Conclusions

This study confirmed that NRBRJ supplementation is effective in improving aerobic exercise capacity and cardiovascular function in healthy males. However, to better understand the combined effects of NRBRJ supplementation and exercise, further research is warranted on the effects on exercise capacity and cardiovascular function considering different factors (e.g., age, sex, environment, and aerobic exercise capacity of participants).

Author Contributions

Study conception and design: X.Y. and H.-Y.P.; data curation: J.-H.C., J.S., Y.S., E.L. and S.-W.K.; formal analysis: X.Y., S.-W.K. and H.-Y.P.; investigation: J.-H.C., J.S., Y.S., E.L. and S.-W.K.; methodology: X.Y., J.-H.C., S.-W.K. and H.-Y.P.; writing—original draft: X.Y. and J.-H.C.; writing—review and editing X.Y., J.-H.C. and H.-Y.P. All authors have read and agreed to the published version of the manuscript.

Funding

This study received no external funding.

Institutional Review Board Statement

The present study was approved by the Institutional Review Board of Konkuk University (7001355-202301-E-616, approved on 11 January 2023) and was conducted in accordance with the Declaration of Helsinki.

Informed Consent Statement

Informed consent was obtained from all the participants involved in the study.

Data Availability Statement

The data presented in this study are available upon request from the first or corresponding author.

Acknowledgments

This paper was supported by Konkuk University in 2024.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Akan, S.; Tuna Gunes, N.; Erkan, M. Red beetroot: Health benefits, production techniques, and quality maintaining for food industry. J. Food Process. Preserv. 2021, 45, e15781. [Google Scholar] [CrossRef]
  2. Vermeer, I.T.; van Maanen, J.M. Nitrate exposure and the endogenous formation of carcinogenic nitrosamines in humans. Rev. Environ. Health 2001, 16, 105–116. [Google Scholar] [CrossRef] [PubMed]
  3. Wruss, J.; Waldenberger, G.; Huemer, S.; Uygun, P.; Lanzerstorfer, P.; Müller, U.; Höglinger, O.; Weghuber, J. Compositional characteristics of commercial beetroot products and beetroot juice prepared from seven beetroot varieties grown in Upper Austria. J. Food Compos. Anal. 2015, 42, 46–55. [Google Scholar] [CrossRef]
  4. Arciero, P.J.; Miller, V.J.; Ward, E. Performance Enhancing Diets and the PRISE Protocol to Optimize Athletic Performance. J. Nutr. Metab. 2015, 2015, 715859. [Google Scholar] [CrossRef] [PubMed]
  5. Lundberg, J.O.; Govoni, M. Inorganic nitrate is a possible source for systemic generation of nitric oxide. Free Radic. Biol. Med. 2004, 37, 395–400. [Google Scholar] [CrossRef] [PubMed]
  6. Cosby, K.; Partovi, K.S.; Crawford, J.H.; Patel, R.P.; Reiter, C.D.; Martyr, S.; Yang, B.K.; Waclawiw, M.A.; Zalos, G.; Xu, X.; et al. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat. Med. 2003, 9, 1498–1505. [Google Scholar] [CrossRef] [PubMed]
  7. Lundberg, J.O.; Carlström, M.; Larsen, F.J.; Weitzberg, E. Roles of dietary inorganic nitrate in cardiovascular health and disease. Cardiovasc. Res. 2011, 89, 525–532. [Google Scholar] [CrossRef] [PubMed]
  8. Wink, D.A.; Hines, H.B.; Cheng, R.Y.; Switzer, C.H.; Flores-Santana, W.; Vitek, M.P.; Ridnour, L.A.; Colton, C.A. Nitric oxide and redox mechanisms in the immune response. J. Leukoc. Biol. 2011, 89, 873–891. [Google Scholar] [CrossRef] [PubMed]
  9. Kozłowska, L.; Mizera, O.; Gromadzińska, J.; Janasik, B.; Mikołajewska, K.; Mróz, A.; Wąsowicz, W. Changes in Oxidative Stress, Inflammation, and Muscle Damage Markers Following Diet and Beetroot Juice Supplementation in Elite Fencers. Antioxidants 2020, 9, 571. [Google Scholar] [CrossRef]
  10. Strijdom, H.; Chamane, N.; Lochner, A. Nitric oxide in the cardiovascular system: A simple molecule with complex actions. Cardiovasc. J. Afr. 2009, 20, 303–310. [Google Scholar]
  11. Coles, L.T.; Clifton, P.M. Effect of beetroot juice on lowering blood pressure in free-living, disease-free adults: A randomized, placebo-controlled trial. Nutr. J. 2012, 11, 106. [Google Scholar] [CrossRef] [PubMed]
  12. Iwasaki, K.; Zhang, R.; Zuckerman, J.H.; Levine, B.D. Dose-response relationship of the cardiovascular adaptation to endurance training in healthy adults: How much training for what benefit? J. Appl. Physiol. 2003, 95, 1575–1583. [Google Scholar] [CrossRef] [PubMed]
  13. Law, M.R.; Morris, J.K.; Wald, N.J. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009, 338, b1665. [Google Scholar] [CrossRef] [PubMed]
  14. Webb, A.J.; Patel, N.; Loukogeorgakis, S.; Okorie, M.; Aboud, Z.; Misra, S.; Rashid, R.; Miall, P.; Deanfield, J.; Benjamin, N.; et al. Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite. Hypertension 2008, 51, 784–790. [Google Scholar] [CrossRef] [PubMed]
  15. Hobbs, D.A.; Kaffa, N.; George, T.W.; Methven, L.; Lovegrove, J.A. Blood pressure-lowering effects of beetroot juice and novel beetroot-enriched bread products in normotensive male subjects. Br. J. Nutr. 2012, 108, 2066–2074. [Google Scholar] [CrossRef] [PubMed]
  16. Kapil, V.; Milsom, A.B.; Okorie, M.; Maleki-Toyserkani, S.; Akram, F.; Rehman, F.; Arghandawi, S.; Pearl, V.; Benjamin, N.; Loukogeorgakis, S.; et al. Inorganic nitrate supplementation lowers blood pressure in humans: Role for nitrite-derived NO. Hypertension 2010, 56, 274–281. [Google Scholar] [CrossRef]
  17. Pedersen, B.K.; Saltin, B. Exercise as medicine—Evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand. J. Med. Sci. Sports 2015, 25 (Suppl. S3), 1–72. [Google Scholar] [CrossRef] [PubMed]
  18. Santos-Parker, J.R.; LaRocca, T.J.; Seals, D.R. Aerobic exercise and other healthy lifestyle factors that influence vascular aging. Adv. Physiol. Educ. 2014, 38, 296–307. [Google Scholar] [CrossRef] [PubMed]
  19. Ammar, A.; Mueller, P.; Trabelsi, K.; Chtourou, H.; Boukhris, O.; Masmoudi, L.; Bouaziz, B.; Brach, M.; Schmicker, M.; Bentlage, E.; et al. Psychological consequences of COVID-19 home confinement: The ECLB-COVID19 multicenter study. PLoS ONE 2020, 15, e0240204. [Google Scholar] [CrossRef]
  20. Wang, J.; Wolin, M.S.; Hintze, T.H. Chronic exercise enhances endothelium-mediated dilation of epicardial coronary artery in conscious dogs. Circ. Res. 1993, 73, 829–838. [Google Scholar] [CrossRef]
  21. Gliemann, L.; Rytter, N.; Tamariz-Ellemann, A.; Egelund, J.; Brandt, N.; Carter, H.H.; Hellsten, Y. Lifelong Physical Activity Determines Vascular Function in Late Postmenopausal Women. Med. Sci. Sports Exerc. 2020, 52, 627–636. [Google Scholar] [CrossRef] [PubMed]
  22. Stamler, J.S.; Meissner, G. Physiology of nitric oxide in skeletal muscle. Physiol. Rev. 2001, 81, 209–237. [Google Scholar] [CrossRef] [PubMed]
  23. Totzeck, M.; Hendgen-Cotta, U.B.; Luedike, P.; Berenbrink, M.; Klare, J.P.; Steinhoff, H.J.; Semmler, D.; Shiva, S.; Williams, D.; Kipar, A.; et al. Nitrite regulates hypoxic vasodilation via myoglobin-dependent nitric oxide generation. Circulation 2012, 126, 325–334. [Google Scholar] [CrossRef] [PubMed]
  24. van Faassen, E.E.; Bahrami, S.; Feelisch, M.; Hogg, N.; Kelm, M.; Kim-Shapiro, D.B.; Kozlov, A.V.; Li, H.; Lundberg, J.O.; Mason, R.; et al. Nitrite as regulator of hypoxic signaling in mammalian physiology. Med. Res. Rev. 2009, 29, 683–741. [Google Scholar] [CrossRef] [PubMed]
  25. Dreissigacker, U.; Wendt, M.; Wittke, T.; Tsikas, D.; Maassen, N. Positive correlation between plasma nitrite and performance during high-intensive exercise but not oxidative stress in healthy men. Nitric Oxide 2010, 23, 128–135. [Google Scholar] [CrossRef] [PubMed]
  26. Joyner, M.J.; Tschakovsky, M.E. Nitric oxide and physiologic vasodilation in human limbs: Where do we go from here? Can. J. Appl. Physiol. 2003, 28, 475–490. [Google Scholar] [CrossRef] [PubMed]
  27. Gladwin, M.T.; Kim-Shapiro, D.B. The functional nitrite reductase activity of the heme-globins. Blood 2008, 112, 2636–2647. [Google Scholar] [CrossRef]
  28. Ferguson, S.K.; Hirai, D.M.; Copp, S.W.; Holdsworth, C.T.; Allen, J.D.; Jones, A.M.; Musch, T.I.; Poole, D.C. Impact of dietary nitrate supplementation via beetroot juice on exercising muscle vascular control in rats. J. Physiol. 2013, 591, 547–557. [Google Scholar] [CrossRef]
  29. Vanhatalo, A.; Fulford, J.; Bailey, S.J.; Blackwell, J.R.; Winyard, P.G.; Jones, A.M. Dietary nitrate reduces muscle metabolic perturbation and improves exercise tolerance in hypoxia. J. Physiol. 2011, 589, 5517–5528. [Google Scholar] [CrossRef]
  30. Domínguez, R.; Cuenca, E.; Maté-Muñoz, J.L.; García-Fernández, P.; Serra-Paya, N.; Estevan, M.C.; Herreros, P.V.; Garnacho-Castaño, M.V. Effects of Beetroot Juice Supplementation on Cardiorespiratory Endurance in Athletes. A Systematic Review. Nutrients 2017, 9, 43. [Google Scholar] [CrossRef]
  31. Benjamim, C.J.R.; Sousa, Y.B.A.; Porto, A.A.; de Moraes Pontes, Y.M.; Tavares, S.S.; da Silva Rodrigues, G.; da Silva, L.S.L.; da Silva Goncalves, L.; Guimaraes, C.S.; Rebelo, M.A.; et al. Nitrate-rich beet juice intake on cardiovascular performance in response to exercise in postmenopausal women with arterial hypertension: Study protocol for a randomized controlled trial. Trials 2023, 24, 94. [Google Scholar] [CrossRef] [PubMed]
  32. Kelly, J.; Fulford, J.; Vanhatalo, A.; Blackwell, J.R.; French, O.; Bailey, S.J.; Gilchrist, M.; Winyard, P.G.; Jones, A.M. Effects of short-term dietary nitrate supplementation on blood pressure, O2 uptake kinetics, and muscle and cognitive function in older adults. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2013, 304, R73–R83. [Google Scholar] [CrossRef]
  33. Park, H.Y.; Jung, W.S.; Kim, S.W.; Seo, J.; Sun, Y.; Choi, J.H.; Kim, J.; Lim, K. Effects of Acute Moderate Hypoxia versus Normoxia on Metabolic and Cardiac Function and Skeletal Muscle Oxygenation during Endurance Exercise at the Same Heart Rate Level. Metabolites 2022, 12, 975. [Google Scholar] [CrossRef] [PubMed]
  34. Bayles, M.P. ACSM’s Exercise Testing and Prescription; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2023. [Google Scholar]
  35. Jones, T.; Dunn, E.L.; Macdonald, J.H.; Kubis, H.P.; McMahon, N.; Sandoo, A. The Effects of Beetroot Juice on Blood Pressure, Microvascular Function and Large-Vessel Endothelial Function: A Randomized, Double-Blind, Placebo-Controlled Pilot Study in Healthy Older Adults. Nutrients 2019, 11, 975. [Google Scholar] [CrossRef]
  36. Berry, M.J.; Justus, N.W.; Hauser, J.I.; Case, A.H.; Helms, C.C.; Basu, S.; Rogers, Z.; Lewis, M.T.; Miller, G.D. Dietary nitrate supplementation improves exercise performance and decreases blood pressure in COPD patients. Nitric Oxide 2015, 48, 22–30. [Google Scholar] [CrossRef]
  37. Bougault, V.; Lonsdorfer-Wolf, E.; Charloux, A.; Richard, R.; Geny, B.; Oswald-Mammosser, M. Does thoracic bioimpedance accurately determine cardiac output in COPD patients during maximal or intermittent exercise? Chest 2005, 127, 1122–1131. [Google Scholar] [CrossRef]
  38. Charloux, A.; Lonsdorfer-Wolf, E.; Richard, R.; Lampert, E.; Oswald-Mammosser, M.; Mettauer, B.; Geny, B.; Lonsdorfer, J. A new impedance cardiograph device for the non-invasive evaluation of cardiac output at rest and during exercise: Comparison with the “direct” Fick method. Eur. J. Appl. Physiol. 2000, 82, 313–320. [Google Scholar] [CrossRef]
  39. Park, W.; Jung, W.S.; Hong, K.; Kim, Y.Y.; Kim, S.W.; Park, H.Y. Effects of Moderate Combined Resistance- and Aerobic-Exercise for 12 Weeks on Body Composition, Cardiometabolic Risk Factors, Blood Pressure, Arterial Stiffness, and Physical Functions, among Obese Older Men: A Pilot Study. Int. J. Env. Res. Public Health 2020, 17, 7233. [Google Scholar] [CrossRef] [PubMed]
  40. Choi, J.H.; Kim, S.W.; Seo, J.; Sun, Y.; Jung, W.S.; Park, H.Y.; Kim, J.; Lim, K. Effects of a Mobile-Health Exercise Intervention on Body Composition, Vascular Function, and Autonomic Nervous System Function in Obese Women: A Randomized Controlled Trial. J. Multidiscip. Health 2023, 16, 1601–1615. [Google Scholar] [CrossRef]
  41. Cohen, J. Statistical Power Analysis for the Behavioral Sciences; Routledge: London, UK, 2013. [Google Scholar]
  42. Cermak, N.M.; Gibala, M.J.; van Loon, L.J. Nitrate supplementation’s improvement of 10-km time-trial performance in trained cyclists. Int. J. Sport. Nutr. Exerc. Metab. 2012, 22, 64–71. [Google Scholar] [CrossRef]
  43. Wilkerson, D.P.; Hayward, G.M.; Bailey, S.J.; Vanhatalo, A.; Blackwell, J.R.; Jones, A.M. Influence of acute dietary nitrate supplementation on 50 mile time trial performance in well-trained cyclists. Eur. J. Appl. Physiol. 2012, 112, 4127–4134. [Google Scholar] [CrossRef] [PubMed]
  44. Pinna, M.; Roberto, S.; Milia, R.; Marongiu, E.; Olla, S.; Loi, A.; Migliaccio, G.M.; Padulo, J.; Orlandi, C.; Tocco, F.; et al. Effect of beetroot juice supplementation on aerobic response during swimming. Nutrients 2014, 6, 605–615. [Google Scholar] [CrossRef]
  45. Tan, R. Dietary Nitrate Supplementation: Physiological Responses during Prolonged Exercise and Optimizing Nitric Oxide Bioavailability. Ph.D. Thesis, University of Exeter, Exeter, UK, 2019. [Google Scholar]
  46. Bailey, S.J.; Fulford, J.; Vanhatalo, A.; Winyard, P.G.; Blackwell, J.R.; DiMenna, F.J.; Wilkerson, D.P.; Benjamin, N.; Jones, A.M. Dietary nitrate supplementation enhances muscle contractile efficiency during knee-extensor exercise in humans. J. Appl. Physiol. 2010, 109, 135–148. [Google Scholar] [CrossRef]
  47. Larsen, F.J.; Schiffer, T.A.; Borniquel, S.; Sahlin, K.; Ekblom, B.; Lundberg, J.O.; Weitzberg, E. Dietary inorganic nitrate improves mitochondrial efficiency in humans. Cell Metab. 2011, 13, 149–159. [Google Scholar] [CrossRef] [PubMed]
  48. de Lima Bezerra, Á.D.; Costa, E.C.; Pacheco, D.A.; Souza, D.C.; Farias-Junior, L.F.; Ritti-Dia, R.M.; Grigolo, G.B.; de Bittencourt Júnior, P.I.H.; Krause, M.; Fayh, A.P.T. Effect of Acute Dietary Nitrate Supplementation on the Post-Exercise Ambulatory Blood Pressure in Obese Males: A Randomized, Controlled, Crossover Trial. J. Sports Sci. Med. 2019, 18, 118–127. [Google Scholar] [PubMed]
  49. Dong, J.Y.; Qin, L.Q.; Zhang, Z.; Zhao, Y.; Wang, J.; Arigoni, F.; Zhang, W. Effect of oral L-arginine supplementation on blood pressure: A meta-analysis of randomized, double-blind, placebo-controlled trials. Am. Heart J. 2011, 162, 959–965. [Google Scholar] [CrossRef] [PubMed]
  50. Palmer, R.M.; Ferrige, A.G.; Moncada, S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987, 327, 524–526. [Google Scholar] [CrossRef]
  51. Siervo, M.; Lara, J.; Ogbonmwan, I.; Mathers, J.C. Inorganic nitrate and beetroot juice supplementation reduces blood pressure in adults: A systematic review and meta-analysis. J. Nutr. 2013, 143, 818–826. [Google Scholar] [CrossRef] [PubMed]
  52. Perez, J.M.; Dobson, J.L.; Ryan, G.A.; Riggs, A.J. The Effects of Beetroot Juice on VO(2)max and Blood Pressure during Submaximal Exercise. Int. J. Exerc. Sci. 2019, 12, 332–342. [Google Scholar]
  53. Miyai, N.; Arita, M.; Miyashita, K.; Morioka, I.; Shiraishi, T.; Nishio, I. Blood pressure response to heart rate during exercise test and risk of future hypertension. Hypertension 2002, 39, 761–766. [Google Scholar] [CrossRef]
  54. Zamani, P.; Rawat, D.; Shiva-Kumar, P.; Geraci, S.; Bhuva, R.; Konda, P.; Doulias, P.T.; Ischiropoulos, H.; Townsend, R.R.; Margulies, K.B.; et al. Effect of inorganic nitrate on exercise capacity in heart failure with preserved ejection fraction. Circulation 2015, 131, 371–380; discussion 380. [Google Scholar] [CrossRef] [PubMed]
  55. Krustrup, P.; Jones, A.M.; Wilkerson, D.P.; Calbet, J.A.; Bangsbo, J. Muscular and pulmonary O2 uptake kinetics during moderate- and high-intensity sub-maximal knee-extensor exercise in humans. J. Physiol. 2009, 587, 1843–1856. [Google Scholar] [CrossRef] [PubMed]
  56. Bailey, S.J.; Winyard, P.; Vanhatalo, A.; Blackwell, J.R.; Dimenna, F.J.; Wilkerson, D.P.; Tarr, J.; Benjamin, N.; Jones, A.M. Dietary nitrate supplementation reduces the O2 cost of low-intensity exercise and enhances tolerance to high-intensity exercise in humans. J. Appl. Physiol. 2009, 107, 1144–1155. [Google Scholar] [CrossRef] [PubMed]
  57. Pinheiro, V.D.S.; da Silva Tavares, A.C.F.; Volino-Souza, M.; de Oliveira, G.V.; Alvares, T.S. Association between Femoral Artery Flow-Mediated Dilation and Muscle Oxygen Saturation Parameters in Healthy, Young Individuals. J. Cardiovasc. Dev. Dis. 2023, 10, 63. [Google Scholar] [CrossRef] [PubMed]
  58. Walker, M.A.; Bailey, T.G.; McIlvenna, L.; Allen, J.D.; Green, D.J.; Askew, C.D. Acute Dietary Nitrate Supplementation Improves Flow Mediated Dilatation of the Superficial Femoral Artery in Healthy Older Males. Nutrients 2019, 11, 954. [Google Scholar] [CrossRef] [PubMed]
  59. Bahra, M.; Kapil, V.; Pearl, V.; Ghosh, S.; Ahluwalia, A. Inorganic nitrate ingestion improves vascular compliance but does not alter flow-mediated dilatation in healthy volunteers. Nitric Oxide 2012, 26, 197–202. [Google Scholar] [CrossRef] [PubMed]
  60. Stewart, A.D.; Jiang, B.; Millasseau, S.C.; Ritter, J.M.; Chowienczyk, P.J. Acute reduction of blood pressure by nitroglycerin does not normalize large artery stiffness in essential hypertension. Hypertension 2006, 48, 404–410. [Google Scholar] [CrossRef] [PubMed]
  61. Dimmeler, S.; Dernbach, E.; Zeiher, A.M. Phosphorylation of the endothelial nitric oxide synthase at ser-1177 is required for VEGF-induced endothelial cell migration. FEBS Lett. 2000, 477, 258–262. [Google Scholar] [CrossRef] [PubMed]
  62. Thijssen, D.H.; Black, M.A.; Pyke, K.E.; Padilla, J.; Atkinson, G.; Harris, R.A.; Parker, B.; Widlansky, M.E.; Tschakovsky, M.E.; Green, D.J. Assessment of flow-mediated dilation in humans: A methodological and physiological guideline. Am. J. Physiol. Heart Circ. Physiol. 2011, 300, H2–H12. [Google Scholar] [CrossRef]
  63. Steven, S.; Jurk, K.; Kopp, M.; Kröller-Schön, S.; Mikhed, Y.; Schwierczek, K.; Roohani, S.; Kashani, F.; Oelze, M.; Klein, T. Themed Section: Redox Biology and Oxidative Stress in Health and Disease. Br. J. Pharm. 2017, 174, 1620. [Google Scholar] [CrossRef]
  64. Grassi, D.; Desideri, G.; Ferri, C. Flavonoids: Antioxidants against atherosclerosis. Nutrients 2010, 2, 889–902. [Google Scholar] [CrossRef]
Healthcare 12 01240 g001
Figure 1. Study design. NRBRJ: nitrate-rich beetroot juice; PLA: placebo; HRmax: maximal heart rate; HR: heart rate; SV: stroke volume; CO: cardiac output; SBP: systolic blood pressure; DBP: diastolic blood pressure; MAP: mean arterial pressure; TPR: total peripheral resistance; baPWV: brachial–ankle pulse wave velocity; FMD: flow-mediated dilation.
Figure 1. Study design. NRBRJ: nitrate-rich beetroot juice; PLA: placebo; HRmax: maximal heart rate; HR: heart rate; SV: stroke volume; CO: cardiac output; SBP: systolic blood pressure; DBP: diastolic blood pressure; MAP: mean arterial pressure; TPR: total peripheral resistance; baPWV: brachial–ankle pulse wave velocity; FMD: flow-mediated dilation.
Healthcare 12 01240 g001
Healthcare 12 01240 g002
Figure 2. Details of the PLA and NRBRJ supplement. NRBRJ: nitrate-rich beetroot juice; PLA: placebo.
Figure 2. Details of the PLA and NRBRJ supplement. NRBRJ: nitrate-rich beetroot juice; PLA: placebo.
Healthcare 12 01240 g002
Healthcare 12 01240 g003
Figure 3. Mean exercise load at 70% maximal heart rate during the 30 min exercise between two trials. CI: confidence interval; NRBRJ: nitrate-rich beetroot juice; PLA: placebo; HRmax: maximal heart rate;. * Significant difference between the PLA and NRBRJ supplement, * p < 0.05.
Figure 3. Mean exercise load at 70% maximal heart rate during the 30 min exercise between two trials. CI: confidence interval; NRBRJ: nitrate-rich beetroot juice; PLA: placebo; HRmax: maximal heart rate;. * Significant difference between the PLA and NRBRJ supplement, * p < 0.05.
Healthcare 12 01240 g003
Healthcare 12 01240 g004
Figure 4. Cardiovascular function during exercise at 70% maximal heart rate between two trials. (a) Change in HR during exercise in each trial. (b) Change in SV during exercise in each trial. (c) Change in CO during exercise in each trial. (d) Change in SBP during exercise in each trial. (e) Change in DBP during exercise in each trial. (f) Change in MAP during exercise in each trial. (g) Change in TPR during exercise in each trial. NRBRJ: nitrate-rich beetroot juice; PLA: placebo; HR: heart rate; SV: stroke volume; CO: cardiac output; SBP: systolic blood pressure; DBP: diastolic blood pressure; MAP: mean arterial pressure; TPR: total peripheral resistance; Suppl: supplementation; Ex: exercise; Inter: interaction. † Significant interaction or main effect of supplement or exercise, † p < 0.05. * Significant difference between the placebo and NRBRJ supplement, * p < 0.05.
Figure 4. Cardiovascular function during exercise at 70% maximal heart rate between two trials. (a) Change in HR during exercise in each trial. (b) Change in SV during exercise in each trial. (c) Change in CO during exercise in each trial. (d) Change in SBP during exercise in each trial. (e) Change in DBP during exercise in each trial. (f) Change in MAP during exercise in each trial. (g) Change in TPR during exercise in each trial. NRBRJ: nitrate-rich beetroot juice; PLA: placebo; HR: heart rate; SV: stroke volume; CO: cardiac output; SBP: systolic blood pressure; DBP: diastolic blood pressure; MAP: mean arterial pressure; TPR: total peripheral resistance; Suppl: supplementation; Ex: exercise; Inter: interaction. † Significant interaction or main effect of supplement or exercise, † p < 0.05. * Significant difference between the placebo and NRBRJ supplement, * p < 0.05.
Healthcare 12 01240 g004
Healthcare 12 01240 g005
Figure 5. The baPWV and FMD before and after exercise between two trials. (a) Change in baPWV in each trial. (b) Change in FMD in each trial. NRBRJ: nitrate-rich beetroot juice; PLA: placebo; baPWV: brachial–ankle pulse wave velocity; FMD: flow-mediated dilation; Suppl: supplementation; Ex: exercise; Inter: interaction. † Significant interaction or main effect of supplement or exercise, † p < 0.05. # Significant difference between before and after exercise in each trial, # p < 0.05. * Significant difference between the placebo and NRBRJ supplement, * p < 0.05.
Figure 5. The baPWV and FMD before and after exercise between two trials. (a) Change in baPWV in each trial. (b) Change in FMD in each trial. NRBRJ: nitrate-rich beetroot juice; PLA: placebo; baPWV: brachial–ankle pulse wave velocity; FMD: flow-mediated dilation; Suppl: supplementation; Ex: exercise; Inter: interaction. † Significant interaction or main effect of supplement or exercise, † p < 0.05. # Significant difference between before and after exercise in each trial, # p < 0.05. * Significant difference between the placebo and NRBRJ supplement, * p < 0.05.
Healthcare 12 01240 g005
Table 1. Participant characteristics (mean ± standard deviation).
Table 1. Participant characteristics (mean ± standard deviation).
ParametersHealthy Men (n = 12)MinimumMaximum
Age (year)25.1 ± 2.321.029.0
Height (cm)179.9 ± 4.4172.1185.2
Weight (kg)83.6 ± 13.369.2110.6
BMI (kg/m2)25.8 ± 3.621.132.6
Fat free mass (kg)67.7 ± 6.157.377.1
Body fat mass (kg)16.0 ± 9.26.433.5
Percent body fat (%)18.2 ± 7.57.730.3
70% HRmax (bpm)136.5 ± 1.5134.0139.0
Note. BMI = body mass index, HRmax = maximal heart rate.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Yuschen, X.; Choi, J.-H.; Seo, J.; Sun, Y.; Lee, E.; Kim, S.-W.; Park, H.-Y. Effects of Acute Beetroot Juice Supplementation and Exercise on Cardiovascular Function in Healthy Men in Preliminary Study: A Randomized, Double-Blinded, Placebo-Controlled, and Crossover Trial. Healthcare 2024, 12, 1240. https://doi.org/10.3390/healthcare12131240

AMA Style

Yuschen X, Choi J-H, Seo J, Sun Y, Lee E, Kim S-W, Park H-Y. Effects of Acute Beetroot Juice Supplementation and Exercise on Cardiovascular Function in Healthy Men in Preliminary Study: A Randomized, Double-Blinded, Placebo-Controlled, and Crossover Trial. Healthcare. 2024; 12(13):1240. https://doi.org/10.3390/healthcare12131240

Chicago/Turabian Style

Yuschen, **e, Jae-Ho Choi, Jisoo Seo, Yerin Sun, Eunjoo Lee, Sung-Woo Kim, and Hun-Young Park. 2024. "Effects of Acute Beetroot Juice Supplementation and Exercise on Cardiovascular Function in Healthy Men in Preliminary Study: A Randomized, Double-Blinded, Placebo-Controlled, and Crossover Trial" Healthcare 12, no. 13: 1240. https://doi.org/10.3390/healthcare12131240

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop